\ [1] Gadducci A, Cosio S, Muraca S, et al. The management of malignant nondysgerminomtous ovarian germcell tumors[J]. Anticancer Res,2003,23(2C):1827-1836. \ [2] Maciejewska M,Bobkiewicz P,Gawrychowski K. Malignant ovarian germcell tumors-clinical characteristics and analysis of outcomes[J].Ginekol Pol,2011,82(5):338-343. \ [3] Sviracevic B,Sedlar S,Malobabic D,et al. Mixed malignant germcell tumor of ovary[J]. Med Preg,2011,64( 1-2) : 93-95. \ [4] 丰有吉,沈铿. 妇产科学[M]. 2版.北京:人民卫生出版社, 2010:347-349. \ [5] Abdel-Hady ES,Abdel-Hady HR,Gamal A, et al. Fertility sparing surgery for ovarian tumors in children and young adults[J].Arch Gynecol Obstet, 2012, 285(2):469-471. \ [6] 孙玮,韩素萍,傅士龙. 卵巢恶性生殖细胞肿瘤( MOGCTs)预后及生育状况分析[J]. 实用妇产科杂志, 2012,28(6):444-448.\ [7] Moniaga NC,Randall LM. Malignant mixed ovarian germcell tumor with embryonal component[J]. J Pediatr Adolesc Gynecol, 2011, 24(1):e1-e3.\ [8] Yoo SC,Kim WY,Yoon JH,et al. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy[J]. Acta Obstet Gynecol Scand,2010, 89(1):126-130.\ [9] Warne LC. Primary treatment with vincristine, dactinomycin and cyclophosphamide in nondysgerminomatous germ cell tumor of theovary[ J]. Gynecol Oncol, 1989, 34(1):155-156. \ [10] Robert J. Morgan A, Ronald D,et al. Ovarian cancer, version 3[J].2012 J Natl Compr Canc Netw, 2012,10:1339-1349. \ [11] Del Mastro L,Giraudi S,Levaggi A,et al. Medical approaches to preservation of fertility in female cancer patients[J]. Expert Opin Pharmacother, 2011, 12(3):387-396. \ [12] Tangjitgamol S,Hanprasertpong J,Manusirivithaya S,et al.Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes[J]. Acta Obstet Gynecol Scand, 2010,89(2):182-189. \ [13] Lee CW,Song MJ,Park ST,et al. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution[J]. World J Surg Oncol, 2011,9: 123. \ [14] 侯志敏, 薛凤霞.卵巢恶性生殖细胞肿瘤保守治疗探讨[J]. 中国实用妇科与产科杂志, 2006,22(4):265-267. \ [15] 郄明蓉,侯敏敏,曹泽毅,等. 卵巢恶性肿瘤年轻患者保留生育功能手术的效果评价[J]. 中华妇产科杂志, 2006,41(4):233-236. \ [16] Weinberg LE,Lurain JR, Diljeet K, et al.Survival and reproductive outcomes in women treated for malignant ovarian germcell tumors[J]. Gynecol Oncol, 2011,121:285-289. \ [17] Ayhan A, Celik H, Taskiran C, et al Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer1[J]. Eur J Gynaecol Oncol, 2003, 24: 223-232. \ [18] Tangir J, Zelterman D, Ma W, et al. Reproductive function after conservative surgery and chemotherapy formalignant germ cell tumors of the ovary[J]. Obstet Gynecol, 2003,101: 251-257.\ [19] Cicin I,Eralp Y,Saip P,et al. Malignant ovarian germcell tumors: a single-institution experience[J]. Am J Clin Oncol, 2009, 32(2):191-196. |